Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-020779
Filing Date
2022-05-26
Accepted
2022-05-26 16:15:33
Documents
2
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 6821
2 EXHIBIT 24 brhc10038049_ex24.htm EX-24 13367
  Complete submission text file 0001140361-22-020779.txt   21464
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27 STRATHMORE ROAD NATICK MA 01760
Business Address
Duey Marc (Reporting) CIK: 0001925150 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39069 | Film No.: 22970176